WebDisclosure WebDisclosure
Basculer en Français
11280 Companies
250617 Keywords
179245 Articles
136434 Press releases
Headlines Articles Press releases Molecular Health GmbH Remove
  1. Home
  2. Companies
  3. Molecular Health GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/04/2025 at 10:05, 1 year 5 months ago

    Molecular Health and Axxam Announce Strategic Partnership in Drug Development

    Drug Development Biopharmaceutical AI Insights Dataome DiscoveryMAXX
  • BRIEF

    published on 06/04/2025 at 10:05, 1 year 5 months ago

    Molecular Health et Axxam annoncent un partenariat stratégique pour le développement de médicaments

    Biopharmaceutique Développement De Médicaments Informations Sur L'IA Dataome DiscoveryMAXX
  • PRESS RELEASE

    published on 06/04/2025 at 10:00, 1 year 5 months ago

    Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development

    Molecular Health and Axxam partner to enhance drug target discovery through AI-driven solutions. Collaboration combines clinical-molecular insights with biological validation for innovative leads
    AI Partnership Drug Development Molecular Health Axxam
    Logo of Molecular Health GmbH
Accesswire
  • Published on 11/04/2026 at 23:10, 7 hours 52 minutes ago

    Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast

  • Published on 11/04/2026 at 23:00, 8 hours 2 minutes ago

    Avino Reports Q3 2026 Financial Results

  • Published on 11/04/2026 at 23:00, 8 hours 2 minutes ago

    Viemed Healthcare Announces Third Quarter 2026 Financial Results

  • Published on 11/04/2026 at 22:15, 8 hours 47 minutes ago

    Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity

  • Published on 11/04/2026 at 22:05, 8 hours 57 minutes ago

    Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 11/05/2026 at 06:58, 3 minutes ago

    Aareal Bank leverages its operational strength to set the course for its strategic future

  • Published on 11/05/2026 at 06:58, 4 minutes ago

    AT&S reports record second-quarter results and fully confirms full-year guidance

  • Published on 11/05/2026 at 06:30, 32 minutes ago

    HENSOLDT increases adjusted EBITDA by 33% and refines guidance for 2026 upwards

  • Published on 11/05/2026 at 06:30, 32 minutes ago

    Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences

  • Published on 11/05/2026 at 06:20, 41 minutes ago

    Zhejiang Showcases Its Cultural and Tourism Appeal in Hamburg at "Come for the Stories" Event

View all EQS
Les Echos
  • Published on 11/04/2026 at 18:00, 13 hours 1 minute ago

    The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026

  • Published on 11/04/2026 at 18:00, 13 hours 1 minute ago

    L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms

  • Published on 11/04/2026 at 17:45, 13 hours 17 minutes ago

    October 2026

  • Published on 11/04/2026 at 17:45, 13 hours 17 minutes ago

    Octobre 2026

  • Published on 11/04/2026 at 17:44, 13 hours 18 minutes ago

    Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy